Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety : design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents

In the present study, two new series of pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety were designed, synthesised, and evaluated for their cytotoxic activity. The benzamide derivatives 16a-e showed higher cytotoxicity than their corresponding Schiff bases 15a-e. Compounds 16a,b,d also inhibited the growth of MCF-7/ADR cells with IC50 in the range of 0.52-6.26 μM. Interestingly, the new compounds were less cytotoxic against normal MRC-5 cells (IC50=0.155-17.08 μM). Mechanistic studies revealed the ability of compounds 16a,b,d to inhibit tubulin polymerisation and multiple oncogenic kinases. Moreover, compounds 16a,b,d induced preG1 and G2/M cell cycle arrest and early apoptosis in MCF-7 cells. The molecular docking analyses of compounds 16a,b,d into the active site in tubulin, CDK-2, and EGFR proteins revealed higher binding affinities compared to the co-crystallised ligands. These preliminary results suggested that compounds 16a,b,d could serve as promising lead compounds for the future development of new potent anticancer agents.HighlightsTwo new series of pyrrolizines bearing 3,4,5-trimethoxyphenyl moieties were synthesized.Compounds 16a,b,d displayed the highest cytotoxicity against the three cancer cell lines.Kinase profiling test revealed inhibition of multiple oncogenic kinases by compounds 16a,b,d.Compounds 16a,b,d exhibited weak to moderate inhibition of tubulin-polymerization.Compounds 16a,b,d induced preG1 and G2/M cell cycle arrest and early apoptosis in MCF-7 cells.Docking studies revealed high binding affinities for compounds 16a,b towards tubulin and CDK-2.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:36

Enthalten in:

Journal of enzyme inhibition and medicinal chemistry - 36(2021), 1 vom: 29. Dez., Seite 1313-1333

Sprache:

Englisch

Beteiligte Personen:

Shawky, Ahmed M [VerfasserIn]
Ibrahim, Nashwa A [VerfasserIn]
Abdalla, Ashraf N [VerfasserIn]
Abourehab, Mohammed A S [VerfasserIn]
Gouda, Ahmed M [VerfasserIn]

Links:

Volltext

Themen:

Antineoplastic Agents
Apoptosis
Cell cycle
Cytotoxicity
Journal Article
Kinase inhibitor
Pyrazoles
Pyrrolizine
Tubulin

Anmerkungen:

Date Completed 27.08.2021

Date Revised 27.08.2021

published: Print

Citation Status MEDLINE

doi:

10.1080/14756366.2021.1937618

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM327018917